China NMPA Inspection - Yingtao Cosmetics Factory, Huadu District, Guangzhou - January 02, 2020

On January 2, 2020, the National Medical Products Administration (NMPA) published an official notification concerning an unannounced inspection targeting Guangzhou Huadu District Yingtao Cosmetics Factory. This document, identified by index number JGXX-2020-10001, serves as a public record of a regulatory action initiated under the NMPA's comprehensive oversight framework, which includes supervision for cosmetics manufacturing. The NMPA, operating under the broader regulatory scope of the China Drug Administration, utilizes dedicated platforms like the Cosmetics Supervision App to ensure industry compliance. While this notification formally announces the inspection event, it does not provide specific details regarding the actual dates the inspection commenced or concluded. Crucially, the document does not enumerate any identified violations, non-compliance issues, or specify any required corrective actions from the factory. Its primary purpose is to inform the public about the initiation of a regulatory assessment, signaling the NMPA's ongoing commitment to monitoring and enforcing standards within the cosmetics sector. The absence of violation details implies that this is purely an initial announcement, with potential findings to be disclosed in subsequent regulatory communications.